Article
Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs.
Drug metabolism and disposition: the biological fate of chemicals - 1 Sept 2012
Walsky Robert L, Obach R Scott, Hyland Ruth, Kang Ping, Zhou Sue, West Michael, Geoghegan Kieran F, Helal Christopher J, Walker Gregory S, Goosen Theunis C, Zientek Michael A
Abstract excerpt
CYP3cide (PF-4981517; 1-methyl-3-[1-methyl-5-(4-methylphenyl)-1H-pyrazol-4-yl]-4-[(3S)-3-piperidin-1-ylpyrrolidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine) is a potent, efficient, and specific time-dependent inactivator of human CYP3A4. When investigating its inhibitory properties, an extreme metabolic inactivation efficiency (k(inact)/K(I)) of 3300 to 3800 ml · min⁻¹ · μmol⁻¹ was observed using human liver microsomes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
